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Abstract  
Background 
Brief depression screening questionnaires may increase detection of depression in 
primary care settings but there have been few validation studies carried out in typical 
populations in low-income countries.  
Methods 
Cultural validation of the Patient Health Questionnaire (PHQ-9/ PHQ-2), the 20-item 
Self-Reporting Questionnaire (SRQ-20) and the Kessler scales (K6/ K10) was carried 
out in 306 adults consecutively attending primary care facilities in small towns in 
Ethiopia. To assess criterion validity, the gold standard assessment for presence of 
Major Depressive Disorder (MDD) was made by Ethiopian psychiatric nurses using 
the Mini International Neuropsychiatric Interview.  
Results 
The prevalence of gold standard MDD was 5.9%, with irritability more common than 
depressed mood or anhedonia. The area under the receiver operating characteristic 
curve indicated good performance of the PHQ-9, SRQ-20, K6 and K10 (0.83 to 0.85) 
but only fair for the PHQ-2 (0.78). No cut-off score had acceptable sensitivity 
combined with adequate positive predictive value. All screening questionnaires were 
associated with disability and the PHQ-9 and SRQ-20 were associated with higher 
health service contacts, indicating convergent validity. Construct validity of all scales 
was indicated by unidimensionality on exploratory factor analysis.  
Limitations 
Test-retest reliability was not assessed.  
Conclusions 
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Brief depression screening questionnaires were found to be valid in primary care in 
this low-income country. However, these questionnaires do not have immediate 
applicability in routine clinical settings. Further studies should evaluate utility of 
indicated screening embedded within health system changes that support MDD 
detection. Investigation of irritability as a core depression symptom is warranted. 
 
 
Keywords: 
Depression; validation; primary health care, sub-Saharan Africa; developing country; 
screening 
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1. Introduction 
The treatment gap for depression in low- and middle-income countries (LMICs) is 
large; in the World Mental Health Survey in China and Nigeria, fewer than 10% of 
people with depression had received treatment in the year of illness onset [1]. 
Undetected depression in rural low-income country community settings has been 
associated with substantial disability, premature mortality and increased attendance at 
health facilities with somatic complaints [2]. Non-detection of depression in primary 
healthcare (PHC) settings is associated with cost and time burdens to both patient and 
health system due to repeated attendance, inappropriate prescribing of non-evidence-
based interventions and poorer prognosis of co-morbid physical health conditions [3]. 
 
Effective treatments for depression that are appropriate and feasible for LMICs exist 
[4, 5] but are not available to the majority of the population [6]. In order to reduce the 
treatment gap for depression, the World Health Organization’s ‘mental health gap 
action programme’ (mhGAP) advocates integration of mental health care into PHC 
services through task sharing, supported by new evidence-based treatment guidelines 
suitable for PHC workers [7, 8]. Depression is a priority disorder for mhGAP; 
however, for successful implementation, increased community awareness and demand 
for care needs to be coupled with improved detection of depression within PHC.  
 
In high-income countries, accurate detection of depression in PHC is more likely in 
the presence of a good therapeutic relationship, greater clinical experience, frequent 
patient contacts and when the patient presents with psychological, rather than somatic, 
symptoms of depression [9]. This presents a great challenge in LMICs where the PHC 
system is often weak, with over-burdened clinics and high turnover of staff who have 
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relatively limited training and clinical experience. In addition, somatic presentations 
of depression are the norm in this setting [10]. 
 
Improving detection of depression by PHC workers is challenging [11]. In high-
income countries, stand-alone training is ineffective and the use of brief, screening 
questionnaires for depression are only effective in improving recognition, treatment 
and outcomes of depression if applied in conjunction with organisational changes, 
such as collaborative care [12, 13]. However, in low-income countries brief 
depression screening tools may have greater utility.   
 
In this paper we present the cultural validation of brief questionnaires for detecting 
depression in PHC settings in Ethiopia. The objective was to examine the potential 
application of such questionnaires to the implementation and evaluation of mental 
health care integrated into primary care in Ethiopia as part of the Programme for 
Improving Mental health CarE (PRIME) [14].  
 
 
2. Material and methods 
2.1 Study design 
A validation study to investigate the criterion, convergent and construct validity of 
brief depression screening questionnaires.  
 
2.2 Setting 
The study was carried out in health centres located in and around Butajira town, 
130km south of the capital city, Addis Ababa, Ethiopia. A psychiatric nurse-led unit is 
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located in the Zonal hospital in Butajira town. However, at the time of the study there 
was no mental health care available in PHC. The PHC facility is staffed by health 
officers and nurses. This validation study was carried out in one urban, two semi-
urban and one rural health centre, selected purposively.   
 
2.3 Brief questionnaires to detect depression 
(1) Self Reporting Questionnaire, 20-item version (SRQ-20) [15] 
The SRQ-20 was developed to improve detection of common mental disorders in 
PHC settings in LMICs [15]. The SRQ items are single-clause questions which 
require a yes/no response and are easily administered in an interview format. The 
items include somatic, anxiety and depressive symptoms, as well as questions about 
suicidal ideation and functional impact, present in the preceding 30 days. The SRQ-20 
has been widely validated and used in LMICs. In Ethiopia, the SRQ-20 has been 
validated for detection of depression in postnatal women [16, 17]. A culturally 
adapted version of SRQ (‘SRQ-F’) lengthened the scale with little improvement in 
psychometric properties [18].   
  
(2) Kessler 6 and 10 item versions (K6/ K10) [19] 
The K10 and K6 scales are widely used tools to assess non-specific psychological 
distress in the previous one month. Each item is rated from 1 to 5, based on the 
persistence of a specific symptom, from “none at all” to “all the time”. The K10 scale 
includes depressive, anxiety and somatic symptoms but not suicidal ideation. The 
Kessler 6-item scale comprises a sub-set of the Kessler 10-item scale (items 2, 3, 5, 7, 
9 and 10). In Ethiopia, the criterion validity of K6 and K10 for detection of depression 
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in postnatal women has been demonstrated [17] but the Kessler has not been 
evaluated in a general PHC setting. 
 
(3) Patient Health Questionnaire, 2- and 9-item versions (PHQ-2 [20] and PHQ-9 
[21]) 
The PHQ-9 is a widely used depression screening scale for PHC in high-income 
countries. The nine items of the PHQ follow the Diagnostic and Statistical Manual 
(DSM) version IV [22] diagnostic criteria for a depressive episode, including suicidal 
ideation, and ask about symptoms present in the preceding two weeks. The four 
response categories refer to the amount of time that the symptom was present (from 
‘not at all’ (0) to ‘nearly every day’ (3)). A tenth item asks about the functional 
impact of the symptoms. Responses to the PHQ-9 can be summed to give a total 
symptom score. Alternatively, the DSM diagnostic algorithm for a major depressive 
episode can be applied to give a categorical diagnosis of depression. The PHQ-2 is 
comprised of the first two items of the PHQ-9 and has been found to be a useful 
screener in PHC settings in high-income countries [20]. The criterion validity of the 
PHQ-9 for detecting depression has been demonstrated in medical out-patients at a 
referral hospital in Addis Ababa, Ethiopia [23].   
 
2.4 Semantic, technical and content validation  
Semantic, technical and content validity in the Ethiopia setting have already been 
established for the Amharic versions of the SRQ-20 [16, 24] and K10 [17]. The PHQ-
9 was translated independently into Amharic by two Ethiopian psychiatrists and then 
back-translated into English. The final version was obtained by expert consensus. 
Moving from a self-completed to an interviewer-administered questionnaire 
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necessitated modifications, in keeping with previous studies from low-income 
countries [25]. See Supplementary Files 1 and 2. 
  
2.5 Criterion, construct and convergent validation study 
Sample 
Consecutive patients attending the four PHC facilities were recruited over a three 
week period in March 2013. Patients were approached after they had consulted the 
PHC worker. Patients were excluded if they required emergency medical attention, 
were unable to converse in Amharic (the official language of Ethiopia), were unable 
to communicate or were suffering from severe mental disorder.  
 
Procedure 
Participants were interviewed by (1) lay data collectors who administered the brief 
depression scales (SRQ-20, K10/K6 and PHQ-9/PHQ-2) and other structured 
questionnaires (see below), and (2) psychiatric nurses who carried out a gold standard 
clinical assessment to determine the presence or absence of MDD. To overcome order 
effects, the administration of the scales and assessments was randomised. Psychiatric 
nurses and lay data collectors were each masked to the outcome of the other 
assessment.   
 
Gold standard measure of depression 
The MINI is a structured diagnostic assessment scale that allows DSM-IV and ICD-
10 diagnosis [26] and has been widely used as a gold standard measure of MDD [27]. 
Adaptations to the MINI MDD module were made in order to improve sensitivity to 
sociocultural expressions of distress. The skip rules were not applied and raters were 
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allowed to explore symptoms once the fully-structured probe questions had been 
asked. A question on irritability was added, based on previous qualitative work and 
clinical experience that indicate this is an important manifestation of depression in the 
setting. After administering the MINI, combined with information gleaned from 
further clinical interview and observation, and considering bereavement and organic 
exclusion criteria, the psychiatric nurses gave their overall clinical judgment as to 
whether the person was suffering from MDD.  
 
Other measures 
The convergent validity of the brief depression scales was evaluated by examining the 
association with frequency of health service use in the preceding three months and 
functional impairment. The World Health Organization Disability Assessment 
Schedule, version 2 (WHODAS 2.0) [28] assesses both the level of functional 
impairment and the number of days lost from work in the previous 30 days due to a 
health condition. The instrument is considered to be cross-culturally applicable and 
the Amharic version has been used in Ethiopia previously [29].  
Sociodemographic characteristics (age, sex, marital status, educational level, area of 
residence and occupation) were measured using structured self-report questions.. 
Participants were also asked systematically about their main reasons for seeking help 
from the health centre and the diagnosis that the health worker had given them.  
 
Training 
The lay-interviewers were all high school completers who are experienced data 
collectors in the field of mental health. The lay data collectors were trained for four 
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days by senior mental health researchers, followed by one day of observed pilot 
interviews. 
Three psychiatric nurses were trained by an Ethiopian psychiatrist for two days in 
administration of the criterion measure (MINI). The training included extensive role 
play and observed piloting of the gold standard assessment. 
 
Sample size 
A formula for calculating sensitivity and specificity for single tests was used [30]. The 
assumptions used for calculating sample size were as follows: anticipated sensitivity 
80%, alpha 0.05, L (desired precision) = 0.1, Z
2 
1-α/2=3.84, prevalence = 20% and loss 
due to incomplete data or other reasons=3%. The required sample size was 316, to 
allow calculation of the sensitivity estimate within the confidence limits of 75% and 
84%.  
 
Data management and quality assurance 
Data were checked for completeness in the field by supervisors and entered on the day 
of data collection where possible. Double data entry with consistency checks was 
carried out using EpiData [31]. An Ethiopian psychiatrist supervised the psychiatric 
nurse assessments. An experienced supervisor observed selected lay interviewer 
assessments.   
 
Data analysis 
Data analysis was carried out using Stata version 13.1 [32]. Receiver Operating 
Characteristic (ROC) curves were plotted. Optimal cut-off scores were identified on 
the basis of the maximum specificity which was not higher than sensitivity. Internal 
12 
 
consistency was evaluated using Cronbach's alpha [33]. At the optimal cut-point, 
sensitivity, specificity, positive and negative predictive values, percentage correct 
classification, Cohen’s kappa and Youden’s index (sensitivity + specificity -1) [34] 
were calculated.  
 
The prevalence ratio for individual depression screening scale items in people with 
MDD vs. people without MDD was calculated using a poisson working model and 
sandwich estimators of the standard errors [35]. Items on the PHQ-9 were 
dichotomised as 0/1 vs. 2/3, and items on the Kessler were dichotomised as 1/3 vs. 
4/5. 
 
Convergent validity was evaluated using non-parametric tests. Spearman’s Rho 
correlation coefficient was calculated for the association between total score on the 
WHODAS 2.0/number of days when unable to function and the total scores of each 
depression screening scale. Kruskal-Wallis test of the equality of medians was used to 
compare the distribution of depression screening scale scores in people who had 
attended the health centre in the previous three months on no occasions, once or two 
or more times.  
 
Construct validity of the depression screening scales was investigated using 
exploratory factor analysis with maximum likelihood extraction and varimax rotation. 
Inspection of eigenvalues and scree plots was used to identify the number of factors to 
be retained as indicators of scale dimensions. As the SRQ-20 has dichotomous 
response categories, tetrachoric correlation matrices were used as the basis for factor 
analysis. 
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In order to investigate misclassification of MDD by the screening scales, a 
multivariable logistic regression analysis was carried out with each scale score 
dichotomised at the optimal cut-off score for detection as the dependent variable. By 
including the gold standard diagnosis of MDD as an independent variable, all other 
associations with the dependent variable were indicative of misclassification. The 
following items were identified as being potentially associated with misclassification 
of MDD: age, sex [36], education, rural vs. urban residence and two items on the 
WHODAS 2.0 (“difficulty standing for long periods” and “difficulty walking long 
distances”) that were more indicative of physical than mental disability [37].   
 
Ethical considerations 
The investigation was carried out in accordance with the latest version of the 
Declaration of Helsinki, the study design was reviewed by the Institutional Review 
Board of the College of Health Sciences, Addis Ababa University and informed 
consent of the participants was obtained after the nature of the procedures had been 
fully explained. All persons identified by the psychiatric nurses as suffering from 
mental disorder were offered appropriate treatment and follow-up with the existing 
Butajira psychiatric service.  
 
Results 
A total of 309 adults were recruited into the study. There were no refusers. Data were 
missing for three participants, giving a final sample of 306. The socio-demographic 
characteristics of participants are described in Table 1.  
 
[Table 1] 
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3.1 Gold standard MDD 
The prevalence of major depressive disorder was 5.9% (n=18) according to the gold 
standard psychiatric nurse assessment using the MINI. Only 11 out of 18 people with 
MDD had either of the core DSM-IV depression symptoms (depression or 
anhedonia); however a further six cases of MDD had mood change in the form of 
irritability (“being easily angry or upset”). Overall, 14/18 cases of MDD had 
irritability (19/286 for non-cases), 9/18 of cases had depressed mood (4/284 non-
cases) and 8/18 of cases had anhedonia (7/287 non-cases).  
 
None of the participants with MDD reported any emotional symptoms as being their 
primary reason for seeking help; however, sleep and appetite problems and ‘anxiety’ 
and ‘depressed mood’ were reported as secondary reasons for attendance (n=3). Two 
participants were undergoing voluntary testing and counselling for HIV, one was 
attending antenatal care and the remainder presented with abdominal complaints 
(n=5), headache (n=4), burning sensations, palpitations, cough, and toothache (n=1 
each). The majority of participants reported that the PHC workers had not informed 
them of the diagnosis. None had been given a diagnosis of MDD by the PHC worker.  
 
3.2 Depression screening scales 
The frequency distributions for all of the depression scales were negatively skewed. 
The median scores (25
th
 and 75
th
 centiles) were as follows: PHQ-9: 12 (10, 18), PHQ-
2: 6 (6, 10), SRQ-20: 3 (1, 8), K10: 12 (10, 18) and K6: 6 (6, 10). There was no 
evidence of ceiling effects, but possible floor effects for the PHQ-2 (58.2% of 
participants scored 0 out of 6) and Kessler scales (52.3% scored the minimum score 
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on the K6 and 42.2% for the K10). Internal consistency, as indicated by Cronbach’s 
alpha, was good (0.84 for PHQ-9, 0.90 for SRQ-20, 0.88 for K10 and 0.85 for K6).   
 
3.3 Criterion validity 
See Table 2. The area under the receiver operating characteristic curve of the 
depression screening scales against the gold standard was very similar for the PHQ-9 
(0.85; 95% confidence interval 0.77, 0.95), SRQ-20 (0.84; 95%CI 0.76, 0.91), K10 
(0.83; 95%CI 0.74, 0.92) and K6 (0.84; 95%CI 0.75, 0.92), but lower for the PHQ-2 
(0.78; 95%CI 0.66, 0.90). See Figure 1. 
 
[Figure 1]  
 
Apart from the PHQ-2, the optimal scale cut-off scores for indicating probable MDD 
for the other scales had Youden’s scores > 0.50 and correct classification in around 
three-quarters of cases; however, the positive predictive value at these cut-off scores 
was very low: under 18% for all scales and only 11.7% for the PHQ-2. See 
Supplementary Table 1.  
 
[Table 2] 
 
When the cut-off score was increased so that the PPV was at least 50%, as per 
recommendations for useful depression scales in PHC settings [38], this led to an 
unacceptable drop in sensitivity. The agreement between the brief screening scales 
and the gold standard was only moderate, as indicated by the kappa scores which 
clustered around 0.20.   
16 
 
 
Applying the DSM-IV diagnostic algorithm to the PHQ item responses, 2.9% (n=9) 
fulfilled criteria for MDD. The PHQ algorithmic diagnosis of MDD had very low 
sensitivity (22.0%) and low PPV (44.0%).  
 
Most of the individual items on each of the depression screening scales were 
significantly more prevalent in people with MDD compared to those without MDD. 
See Table 3. 
 
[Table 3] 
 
The prevalence ratios for items in the PHQ-9 were higher than for most of the other 
scales, in particular when compared to the SRQ-20. Somatic symptoms tended to 
discriminate less well than cognitive symptoms between people with and without 
MDD.   
 
3.4 Convergent validity 
 
[Table 4] 
 
All of the depression screening scales were highly correlated with WHODAS 2.0 
disability score and the number of days of disability in the preceding month (See 
Table 4). Increasing numbers of previous visits with a health centre were associated 
with higher scores on the PHQ-9 and the SRQ-20 but not on the PHQ-2 or the Kessler 
scales.   
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3.5 Construct validity 
The PHQ-9 and Kessler 10 were unidimensional on exploratory factor analysis. For 
these scales, all items loaded onto the resulting factor with an item-factor correlation 
of 0.35 or more. For the SRQ-20, two factors had Eigenvalues greater than 1.0 but 
there was substantial cross-loading of items and, therefore, a single factor solution 
was considered most meaningful. Items 16 (worthlessness) and 18 (fatigue) of the 
SRQ-20 did not load onto any of the factor models. See Supplementary Figure 1 and 
Supplementary Tables 2 to 4.  
 
3.6 Misclassification 
See Table 5. In the multivariable model, misclassification of MDD was associated 
with lower educational level and the presence of physical disability.  
 
[Table 5] 
 
Discussion 
In this validation study of brief depression screening questionnaires in PHC settings in 
Ethiopia, there was evidence of criterion, convergent and construct validity for the 
PHQ-9, SRQ-20, K10 and K6. The two item version of the PHQ (PHQ-2) had less 
good criterion validity and the PHQ DSM-IV diagnosis of MDD was extremely 
insensitive. All scales were affected by measurement bias, with lower educational 
level and the presence of physical disability associated with misclassification of 
MDD. None of the scales combined sufficiently high positive predictive values and 
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sensitivity for routine screening for MDD in unselected populations in clinical 
settings.   
 
The similarity in the psychometric properties of the PHQ-9, SRQ-20, K6 and K10 for 
detection of MDD is perhaps surprising, although in keeping with a previous head-to-
head comparison in India [38]. The PHQ-9 and K10/6 item response categories 
measure the persistence of symptoms whereas the SRQ-20 item response categories 
only measure the existence of symptoms, regardless of severity or persistence. In the 
low-literacy setting of this study it is possible that the potential gains in accuracy were 
offset by the complexity of the multiple response categories.  The reporting time 
periods also differ between the scales: 30 days for the SRQ-20 and K10/6, and two 
weeks for the PHQ-9,but this did not result in a higher prevalence of ‘probable MDD’ 
at the optimal cut-off point. Furthermore, the SRQ-20 was designed as a measure of 
common mental disorders, combining depressive, anxiety and somatic symptoms, and 
the K10/6 similarly measures non-specific psychological distress whereas the PHQ-9 
items closely follow the DSM-IV diagnostic criteria. This finding accords with our 
previous validation work in Ethiopia [39], whereby the SRQ-20 was found to be a 
more valid screening measure of MDD in the postnatal period than a specific 
depression measure.  
 
The dramatic loss in sensitivity of the PHQ-9 resulting from application of the DSM-
IV diagnostic criteria raises concerns about the assumption that the core symptoms of 
MDD (depressed mood and anhedonia) are the same across cultures. In our study, 
only 11 out of 18 participants diagnosed as having MDD by the experienced 
Ethiopian mental health professionals reported either of the core mood symptoms. 
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Seven out of the other eight people with MDD presented with irritability, which was 
added to the MINI for our study due to the perceived usefulness in clinical practice in 
Ethiopia. Irritability is included in DSM-V as a core symptom of depression in young 
people [40]. In the National Co-morbidity Replication Survey from the US, irritability 
was a common symptom in people with MDD, although was rarely present in the 
absence of depressed mood [41]. The addition of irritability to core diagnostic criteria 
for depression may be more applicable within Ethiopia. Although the area is complex 
and requires further study, irritability and anger are strongly proscribed in Ethiopian 
culture and identified readily as deviant states. The same may not be true for sadness, 
which may provoke less societal reaction. As we have argued previously, the 
applicability of the concept of anhedonia in a collectivist and religious culture may be 
limited and contribute to low reporting of this symptom [16].  
 
The optimal cut-off scores for detecting MDD with the brief questionnaires were 
lower than those found in validation studies conducted in high-income countries. A 
recent review of optimal cut-off scores for the PHQ-9 [42] found that PHQ-9 cut-off 
scores ranging between 8 and 11 performed well in identifying probable MDD. That 
review included five studies from middle-income countries but no low-income 
countries. However, studies of PHQ-9 validity in low-income countries from sub-
Saharan Africa (Cameroon and Ghana) found low sensitivity at the standard cut-off 
point [37, 43]. African validation studies of the PHQ-9 which have found higher cut-
off points were conducted in well-educated, urban populations [44, 45].  
 
The performance of the brief depression questionnaires was limited by measurement 
bias in this study, with misclassification associated significantly with lower 
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educational level and physical disability. Previously we found that depression 
screening questionnaires that were developed in Western country settings perform 
better in urban than rural Ethiopia [16, 17]. Mental health literacy, which is related to 
general levels of education, is likely to play an important part in the performance of 
self-report depression questionnaires. Bias due to misclassification of symptoms of 
physical illness as expressions of emotional distress is a recognised problem in 
applying depression screening scales in a PHC setting with high burden of physical 
health problems. In this study, somatic symptoms were less discriminating than items 
that were more cognitive in nature. However, the most frequently endorsed symptoms 
in people with gold standard MDD were somatic in nature. Furthermore, the 
symptoms motivating attendance at the PHC facility were all somatic in nature, 
underlining the importance of somatic symptoms in detection of depression in the 
PHC setting.  
 
A limitation of the study was that we were unable to evaluate test-retest reliability due 
to feasibility constraints.  
 
Conclusions 
Overall there was little to distinguish between the validity of the PHQ-9, SRQ-20 and 
K10/6. The PHQ-9 and SRQ-20 had better convergent validity when compared to the 
K10/6 as well as the advantage of incorporating routine enquiry about suicidal 
ideation. The theoretical advantage of the PHQ-9 in allowing diagnosis of MDD using 
DSM criteria was not realised in practice and raises questions about the direct 
applicability of diagnostic algorithms compared to simple symptom counts. The 
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utility of ‘irritability’ as an important mood manifestation of MDD in this Ethiopian 
setting requires further investigation.  
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Figure 1: Receiver Operating Characteristics Curves for the Patient Health 
Questionnaire (2- and 9-item), Self-Reporting Questionnaire and Kessler scales (6- 
and 10-item) 
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Table 1: Characteristics of validation sample attending primary health care centre (n=306) 
 
Characteristic 
 
N (%) 
Sex 
Male 
Female 
 
115 (37.6) 
191 (62.4) 
Age (years) 
< 20 
20 to 29 
30 to 39 
40 to 49 
50 or more 
 
47 (15.4) 
137 (44.8) 
62 (20.3) 
28 (9.2) 
32 (10.4) 
Marital status 
Never married 
Married 
Widowed or divorced 
 
112 (37.2) 
176 (58.5) 
13 (4.3) 
Educational status 
No education 
Primary 
Secondary 
11
th
 grade or above 
 
69 (22.7) 
62 (20.4) 
85 (28.0) 
88 (29.0) 
Occupation 
Housewife 
Student 
Government employee  
Farmer 
Merchant 
Daily labourer 
Unemployed 
Other 
 
74 (24.2) 
55 (18.0) 
48 (15.7) 
40 (13.1) 
33 (10.8) 
33 (10.8) 
12 (3.9) 
 11 (3.6)  
Residence 
Urban 
 
193 (63.3) 
Rural 112 (36.7) 
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Table 2: Optimal cut-off scores for detection of Major Depressive Disorder (MDD) and associated validity coefficients 
 
 Prevalence of 
probable 
MDD 
Sensitivity Specificity Positive 
Predictive 
Value 
Negative 
Predictive 
Value 
% classified 
correctly 
Youden’s 
index 
Kappa 
Patient Health 
Questionnaire (PHQ)-9 
        
≥4 38.9 88.9 64.2 13.5 98.9 65.7 0.53 0.15 
≥5 28.8 83.3 74.7 17.1 98.6 75.2 0.58 0.21 
≥6  22.9 77.8 80.6 20.0 98.3 80.4 0.58 0.25 
         
PHQ-2         
≥1 41.8 83.3 60.8 11.7 98.3 62.1 0.44 0.11  
≥2 23.2 55.6 78.8 14.1 96.6 77.5 0.34 0.14 
≥3 8.5 33.3 93.1 23.1 95.7 89.5 0.26 0.22 
         
PHQ diagnosis of MDD 2.9 22.0 98.0 44.0 95.0 94.0 0.20 0.27 
         
Self-Reporting 
Questionnaire-20 
        
≥7 32.0 83.3 71.2 15.3 98.6 71.9 0.55 0.18 
≥8  29.1 83.3 74.3 16.9 98.6 74.8 0.58 0.20 
≥9 23.5 72.2 79.5 18.1 97.9 79.1 0.52 0.22 
         
Kessler-10         
≥17 28.1 83.3 75.4 17.4 98.6 75.8 0.59 0.21 
≥18 26.5 77.8 76.7 17.3 98.2 76.8 0.55 0.21 
≥19 20.9 61.1 81.6 17.2 97.1 80.4 0.43 0.19 
         
Kessler-6         
≥8  44.1 94.4 59.0 12.6 99.4 61.1 0.53 0.13 
≥9  29.7 77.8 73.3 15.4 98.1 73.5 0.51 0.18 
≥10 28.8 72.2 74.0 14.8 97.7 73.9 0.46 0.16 
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Table 3: Discrimination between cases and non-cases of major depressive disorder (MDD) by items of 
brief depression screening scales 
 
 Prevalence in 
non-cases (%) 
Prevalence in 
people with 
gold standard 
MDD  
(%) 
Prevalence ratio 
(95% confidence 
interval) 
Patient Health Questionnaire, 9 item    
Trouble concentrating 0.7 11.1 16.00 (2.38, 107.44) 
Feeling down, depressed or hopeless 3.1 27.8 8.89 (3.32, 23.82) 
Feeling bad about yourself 2.8 16.7 6.00 (1.74, 20.74) 
Retardation or agitation 2.8 16.7 6.00 (1.74, 20.74) 
Tired or low energy 8.6 50.0 5.76 (3.17, 10.45) 
Appetite problem 9.3 50.0 5.33 (2.97, 9.58) 
Sleep problem 8.6 44.4 5.12 (2.70, 9.70) 
Little interest or pleasure 9.0 38.9 4.31 (2.17, 8.56) 
Better off dead 9.0 22.2 2.46 (0.96, 6.30) 
    
Self Reporting Questionnaire, 20-item 
Thought of ending life 5.2 22.2 4.25 (1.57, 11.52) 
Difficult to make decisions 9.7 38.9 4.13 (2.09, 8.18) 
Feel worthless 13.8 50.0 3.68 (2.14, 6.36) 
Trouble thinking clearly 21.0 72.2 3.47 (2.41, 4.99) 
Feel unhappy 21.7 66.7 3.10 (2.09, 4.60)  
Poor digestion 26.9 83.3 3.08 (2.32, 4.07) 
Hands shake 10.7 27.8 2.67 (1.17, 6.05) 
Difficult to enjoy activities 12.8 33.3 2.59 (1.26, 5.31) 
Easily frightened 24.5 61.1 2.51 (1.65, 3.83) 
Lost interest in things 19.4 44.4 2.32 (1.31, 4.10) 
Feel tired 29.4 66.7 2.28 (1.57, 3.31) 
Easily tired 34.3 77.8 2.28 (1.70, 3.06) 
Daily work suffering 24.6 55.6 2.28 (1.44, 3.61) 
Unable to play useful part in life 18.3 38.9 2.15 (1.14, 4.03) 
Nervous, tense or worried 34.1 72.2 2.12 (1.53, 2.95) 
Sleep badly 32.1 66.7 2.09 (1.44, 3.02) 
Crying more than usual 8.6 16.7 2.00 (0.66, 6.03) 
Poor appetite 39.3 77.8 1.98 (1.49, 2.64) 
Uncomfortable stomach 25.3 44.4 1.77 (1.02, 3.09) 
Frequent headaches 49.7 72.2 1.45 (1.07, 1.98) 
    
Kessler 10 item (Kessler 6 item*)    
So restless that can't sit still 0.3 11.1 32.00 (3.03, 337.76) 
Feel hopeless* 1.0 22.2 21.33 (5.15, 88.39) 
So nervous that can't calm down 1.0 11.1 10.67 (1.90, 60.02) 
Restless or fidgety* 1.0 11.1 10.67 (1.90, 60.02) 
Feel worthless* 1.7 16.7 9.60 (2.48, 37.11) 
Feel nervous* 3.8 27.8 7.27 (2.83, 18.72) 
So depressed nothing can cheer up* 2.4 16.7 6.86 (1.93, 24.37) 
Feel depressed 5.2 27.8 5.71 (2.31, 14.12) 
Everything an effort* 1.4 5.6 4.00 (0.47, 34.08) 
Tired out 5.2 11.1 2.29 (0.56, 9.32) 
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Table 4: Convergent validity of depression screening scales with disability and health service utilisation 
 
 PHQ-9 PHQ-2 SRQ-20 Kessler-10 Kessler-6 
 
Disability Spearman’s Rho correlation coefficient for association with depression screening scales* 
 
WHODAS 2.0 total score 0.77 
 
0.66 0.74 0.74 0.71 
WHODAS 2.0 number of disability 
days in preceding month 
 
0.60 0.57 0.56 0.58 0.55 
      
Previous health centre visits Median depression scale scores (25
th
 and 75
th
 centiles) for number of previous health centre visits 
 
0 visits 
1 visit 
2 or more visits 
 
2 (0, 4) 
3 (1, 7) 
3 (1, 8) 
 
0 (0, 1) 
0 (0, 2) 
1 (0, 2) 
 
2 (1, 7) 
5 (1, 11) 
5.5 (1, 12) 
 
12 (10, 17) 
14 (10, 19) 
13.5 (10, 20) 
 
6 (6, 10) 
8 (6, 12) 
8 (6, 12) 
      
χ2(degrees of freedom), p-value† 
 
7.34 (2)  
p = 0.0254 
2.53 (2) 
p = 0.2826 
6.30 (2) 
p = 0.0428 
1.49 (2) 
p = 0.4745 
2.86 (2) 
p = 0.2388 
 
 
PHQ-9 and PHQ-2: Patient Health Questionnaire, 9 and 2 item versions; SRQ-20: Self Reporting Questionnaire, 20 item version; Kessler-10 and Kessler-6: Kessler 10 and 6 
item version 
*all correlations significant at the level of p<0.0001 
†
Kruskal-Wallis equality of populations rank test 
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Table 5: Multivariable model for factors associated with misclassification of depression status 
       
 Adjusted odds ratios for association with misclassification of  
major depressive disorder (MDD) at optimal screening scale cut-off 
scores
±
 
 PHQ-9 ≥ 5 
(n=302) 
SRQ-20 ≥ 8 
(n=302) 
Kessler-10 ≥ 18 
(n=302) 
    
Age (years) 0.99 (0.96, 1.02) 1.00 (0.98, 1.03) 0.98 (0.95, 1.01) 
Female sex 0.72 (0.37, 1.39) 0.82 (0.43, 1.56) 0.95 (0.50, 1.80) 
Years of education 0.90 (0.83, 0.97) 0.92 (0.85, 0.99) 0.92 (0.85, 0.99) 
Rural residence 0.80 (0.40, 1.61) 0.97 (0.50, 1.90) 0.81 (0.41, 1.60) 
Standing a long time  3.01 (1.49, 6.09) 2.76 (1.38, 5.55) 2.96 (1.49, 5.89) 
Walking long distances 2.51 (1.13, 5.55) 4.85 (2.17, 10.85) 2.17 (0.99, 4.77) 
    
 
±
Gold standard diagnosis of MDD included in the model  
PHQ-9: Patient Health Questionnaire, 9 item version 
SRQ-20: Self-Reporting Questionnaire, 20-item version 
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